Researchers sought to understand the characteristics of teens with a history of depression who indicated on Patient Health Questionnaire item 9 that they had no thoughts of self-harm shortly before an intentional incident of self-harm.

AAP leaders continue to call for a federal ban on menthol-flavored tobacco products.

Adolescent substance use in 2023 stayed below pre-pandemic levels.

Media reports indicate the new rules will be delayed.

A new study shows emergency department visits that involved cannabis increased significantly during the pandemic compared to 2019, including among children ages 10 and under and 11-14.

Naloxone nasal spray, also known as Narcan, can reverse an opioid overdose within minutes.

Two studies reflect the increased use of e-cigarettes among youths.

Officials will allow the prescribing of controlled medications, including buprenorphine, via telehealth visits through Nov. 11.

Fentanyl deaths among children and teens surged during the COVID-19 pandemic, quadrupling from 2018-2021.

More than 5.6 million people in the U.S. ages 12 and older reported opioid use disorder in the past year.

Results of the 2022 Monitoring the Future survey show little to no increases from 2021 in use of most illicit drugs and alcohol among students in eighth, 10th and 12th grades.

An FDA and CDC study showed an estimated 3 million U.S. middle and high school students reported using a tobacco product within the past 30 days.

The Food and Drug Administration sent a warning letter to the manufacturer of nicotine-flavored gummy products because it does not have authorization to manufacture, sell or distribute the products in the U.S.

The author of the article on deceptive cannabis ads failed to acknowledge that addiction to alcohol, tobacco and opioids has significantly more deleterious consequences to patients’ long-term health than cannabis.

An estimated 8.7 million children live with parents impacted by substance use disorder.

Pediatricians should take time to discuss cannabis use with adolescents due to the negative outcomes associated with use, the changing legal landscape and youths’ vulnerability to advertising.

Decreases were noted across many different substances, including alcohol, marijuana and vaped nicotine.

The Food and Drug Administration (FDA) is warning health care providers about risks related to abuse/misuse of propylhexedrine, an over-the-counter nasal decongestant inhaler. Serious harm can occur, including abnormal heart rhythm, high blood pressure and paranoia and death.

More than 83,000 opioid overdose deaths were reported from June 2019 to June 2020, the highest number ever recorded in a 12-month period, according to provisional data from the Centers for Disease Control and Prevention.

The AAP has supported changes to make it easier to prescribe buprenorphine, including endorsing a bill in 2020 that would have eliminated the need for a waiver.